Zoetis executive joins Valeant as CFO
NEW YORK — Paul Herendeen has left Zoetis Inc. to become executive vice president of finance and chief financial officer at Valeant Pharmaceuticals International Inc. Valeant said Monday that Herendeen takes over the CFO role from Robert Rosiello, who has been appointed executive vice president of corporate development and strategy. “I am pleased to bring
